Non-Current Liabilities

Merck & Co.·Balance Sheet Statement·10 metrics

Breakdown

Metric	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Long-term debt	$37.8B	$38.1B	$37.1B	$34.8B	$35.4B	$41.4B	$49.3B	$49.1B
Other non-current liabilities	$7.3B	$7.5B	$6.5B	$6.7B	$7B	$7.7B	$7.7B	$7.6B
Total liabilities	—	—	$538M	—	—	—	$324M	$229M
Debt Maturity - 2027	—	—	$1.7B	—	—	—	$2.7B	—
Deferred tax liabilities	—	—	$3.1B	—	—	—	$5.6B	—
Deferred Tax Liabilities - Foreign Earnings	—	—	$371M	—	—	—	$338M	—
Secured Borrowings Cash Right to Reclaim	$0	$0	$0	$0	$97M	$0	$0	$0
Unrecognized Tax Benefits	—	—	$2.3B	—	—	—	$2.5B	—
Unrecognized Tax Benefits - Impacting Effective Tax Rate	—	—	$2.2B	—	—	—	$2.5B	—
Unrecognized Tax Benefits - Income Tax Penalties and Interest Accrued	—	—	$437M	—	—	—	$546M	—